JHS Svendgaard Laboratories Ltd. — Capital/Financing Update 2025

Nov 14, 2025

CIN : L74110HP2004PLC027558

To November 14, 2025

==> picture [72 x 54] intentionally omitted <==

The Listing Department Bombay Stock Exchange Limited Department of Corporate Services Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai – 400001 Scrip Code: 532771		The Listing Department National Stock Exchange of India Limited Exchange Plaza, C-1, Block-G Bandra Kurla Complex Mumbai – 400051 Trading Symbol: JHS

Re: Intimation of Grant of Options under JHS Svendgaard Laboratories Limited Employee Stock Option Scheme – 2025 (“Scheme”).

Dear Sir/Ma’am,

In accordance with the provisions of the Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that a meeting of the Nomination and Remuneration Committee (“Committee”) of JHS Svendgaard Laboratories Limited (“Company”) was held on 14[th] November, 2025 at 11:00 A.M. and concluded at 11:50 A.M. for grant of 31,30,000 Employee Stock Options (“Options”) convertible into equal number of Equity Shares of the Company of face value of Rs. 10/- each, under the JHS Svendgaard Laboratories Limited Employee Stock Option Scheme – 2025 (“Scheme”).

The relevant disclosure, as required under Regulation 30 of the SEBI (LODR) Regulations, 2015, pursuant to SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024, are as under :

==> picture [482 x 247] intentionally omitted <==

----- Start of picture text -----

Sl. Particulars Details
No.
1. Name of the Scheme JHS Svendgaard Laboratories Limited Employee
Stock Option Scheme – 2025 (“Scheme”)
2. Brief details of options granted Grant of 31,30,000 options to eligible employees.
Effective grant date 14 [th] November, 2025
3. Whether the Scheme is in terms of SEBI Yes
(SBEB & SE) Regulations, 2021 (if
applicable)
4. Total number of shares covered by these 31,30,000 Options which shall be convertible into
options equal number of Shares of face value Rs. 10 each.
----- End of picture text -----

==> picture [491 x 62] intentionally omitted <==

CIN : L74110HP2004PLC027558

==> picture [72 x 54] intentionally omitted <==

==> picture [482 x 622] intentionally omitted <==

----- Start of picture text -----

5. Pricing Formula Under this Scheme, the Exercise Price will be decided
by the Committee at the time of Grant and shall be
linked with the Market Price as defined in the Scheme.
The Committee has the power to provide a suitable
discount on such price as arrived above. However, in
any case the exercise price shall not go below the face
value of the Share of the Company.
Accordingly, the exercise price was determined at Rs.
10 per Option.
6. Options Vested Not Applicable, as this outcome is pertaining to grant
of Options under the Scheme.
7. Time within which option may be After Vesting, Options can be exercised either wholly
exercised or partly, within a maximum exercise period of 5
(Five) years from the date of respective vesting,
during the Exercise Window as intimated from time to
time to the Grantee, after submitting the Exercise
Application along with payment of the Exercise Price,
applicable taxes and other charges, if any.
8. Options exercised Not Applicable, as this outcome is pertaining to grant
of Options under the Scheme.
9. Money realized by exercise of Options
10. The total number of Shares arising as a 31,30,000 Equity Shares of face value Rs. 10/- each
result of exercise of Option will arise deeming all granted options are vested and
exercised.
11. Options lapsed Not Applicable, as this outcome is pertaining to grant
of Options under the Scheme.
12. Variation in terms of Options
13. Brief details of significant terms The Scheme shall be implemented through direct
route for extending the benefits to the Eligible
Employees by the way of fresh allotment from the
Company.
The grant of Options is based upon the eligibility
criteria as mentioned in the Scheme.
----- End of picture text -----

==> picture [491 x 62] intentionally omitted <==

CIN : L74110HP2004PLC027558

==> picture [72 x 54] intentionally omitted <==

==> picture [482 x 395] intentionally omitted <==

----- Start of picture text -----

The Vesting Period shall commence from a period of
1 (One) year from the Grant Date and shall extend
upto a maximum period of 5 (Five) years from the
Grant Date, at the discretion of and in the manner
prescribed by the Committee and set out in the Grant
Letter.
Provided further that in the event of death or
permanent disability of a Grantee, the minimum
vesting period of one year shall not be applicable and
in such instances, the Options shall vest in terms of
SEBI (SBEB & SE) Regulations, on the date of the
death or Permanent Disability.
After Vesting, Options can be exercised either wholly
or partly, within a maximum Exercise Period of 5
(Five) years from the date of respective Vesting,
during the Exercise Window as intimated from time to
time to the Grantee, after submitting the Exercise
Application along with payment of the Exercise Price,
applicable taxes and other charges, if any.
14. Subsequent changes or cancellation or Not Applicable, as this outcome is pertaining to grant
exercise of such Options of Options under the Scheme.
15. Diluted earnings per share pursuant to the
issue of equity shares on exercise of
Options.
----- End of picture text -----

This information shall be made available on the website of the Company viz., www.svendgaard.com.

Kindly take the same on records.

Thanking You, For JHS Svendgaard Laboratories Limited KOMAL Digitally signed by KOMAL JHA JHA Date: 2025.11.14 12:01:48 +05'30' Komal Jha Company Secretary & Compliance officer Encl: A/a

==> picture [491 x 62] intentionally omitted <==